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EXECUTIVE SUMMARY
In order to examine transitions between heroin and amphetamine injecting, structured interviews were conducted with 151 primary heroin injectors and 145 primary amphetamine injectors. Four major sub-groups were examined: i) current heroin injectors who initially injected heroin (N=91), ii) current heroin injectors who initially injected amphetamines (N=60), iii) current amphetamine users who initially injected amphetamines (N=121) and iv) current amphetamine users who initially injected heroin (N=24). r oes not fit the complexity of transitional movement.
phetamine to heroin was ssociated with more frequent injection, more money spent on drugs and more ug use, were no less kely to have recently shared used injecting equipment, and had the similar Contrary to expectation, heroin use is not ecessarily a stable endpoint for injecting careers, but is in many cases simply a rther transition in primary drug use.
vii
The major finding of this study was the complexity of transition patterns between primary injection of the two drug classes. Six major transition pathways were detected among these subjects: heroin-amphetamines-heroin (N=30), heroin-heroin (N=61), amphetamines-heroin (N=60), heroin-amphetamines (N=24), amphetamines-amphetamines (N=80) and amphetamines-heroin-amphetamines (N=41).
While the transition from amphetamines to heroin injecting was more common than the reverse case, there was substantial movement in both directions. A simple pattern in which the move to heroin injection is viewed as an endpoint in terms of drug use caree d
The main reasons given by subjects who had moved from injecting amphetamines to heroin related to a dislike of the negative physical and psychological effects of regular amphetamine use. Reasons for moving from heroin to amphetamines were more diverse and included the physical effects of heroin and the associated lifestyle, the positive effects of amphetamines such as energy and euphoria, and the injection of amphetamines for intoxicating effects whilst maintained on methadone. A transition from am a frequent crime.
Current primary heroin injectors appeared more socially dysfunctional in terms of crime, unemployment and general social adjustment. However, primary amphetamine injectors had higher levels of current polydr li levels of general and psychiatric health to primary heroin injectors.
While, overall, there was a small preponderance of movement from primary amphetamine injecting to primary heroin injecting, there was considerable movement in both directions. n fu 1 ther illicit drugs. nsiderable concern.
INTRODUCTION
Injecting drug users (IDU) typically have long histories of polydrug use [1] [2] [3] [4] [5] . In a recent study of Australian heroin users, the mean number of drug classes ever used by subjects was 9.0, with 5.3 classes used in the preceding six months 3 . A similar picture has emerged for primary amphetamine users, who appear to have even wider polydrug use patterns 2 . Recent studies have also indicated that IDU meet the criteria for a large number of dependence diagnoses, both lifetime and current [3] [4] [5] . Such results are consistent with the model proposed by Kandel 6 , in which illicit drug users are argued to progress through sequential stages of drug use, commencing with the use of the licit drugs alcohol and tobacco, progressing to the use of cannabis and finally to o
There is evidence that the use of heroin is increasing in Australia. The number of heroin overdose fatalities has increased markedly during the 1990s 7 , and there have been increasing demands for treatment of heroin dependence in recent years 8, 9 . The average age of heroin users has also dropped in recent years, indicating the introduction into heroin use of new, younger users 8, 9 . This apparent increase in heroin use has caused co Amphetamines and heroin are the two most commonly injected drugs in Australia. One possible factor behind the increase in heroin use is increasing numbers of regular injecting amphetamine users making a transition to regular injecting heroin use. This observation has been made by both IDU themselves and drug service personnel 8, 9 . Recent Australian studies of heroin users have also indicated that approximately a half of current heroin users injected amphetamines before they began injecting heroin 3, 9 . Amphetamine injectors are also typically younger than samples of heroin users, indicating that they may possibly be at an earlier stage of an IDU career 2 . Certainly the high purity of Sydney heroin and its relatively low price may make heroin an attractive option [8] [9] [10] . Given the large increase in amphetamine use that occurred in Australia during the mid-1980s to mid-1990s 11 , the route from amphetamine Such studies have examined transitions between routes of administration of heroin 13, 15 , amphetamines 12 and benzodiazepines 14 . To date, however, no study has examined transitions between the injection of different drug classes. In order to ascertain the degree of movement between the primary injection of amphetamines and of heroin, the current study used the methodologies developed in the earlier studies of routes of administration within drug classes.
Given the data and observations cited above, it was anticipated that the o primary amphetamine injecting to primary heroin injecting. 
Procedure
All subjects were volunteers who were paid A$30 for their participation in the study. 
Drug use history
In order to gain an indication of overall drug use, respondents were asked which drug classes they had ever used, which ones had they ever injected, and which ones had they injected in the last 6 months. An estimation of how many days they had used each of the drug classes during the 6 months preceding interview was also ought. Further questions were asked about the first drug ever injected and how old s they were when they first injected.
Heroin and amphetamine dependence
Current dependence on heroin and amphetamines were measured using the Severity of Dependence Scale (SDS) 16 . This is a 5-item scale that measures sychological dependence over the preceding 12 months. Scores range from 0-15, ative of a higher degree of dependence on the p with higher scores being indic particular drug.
Needle risk behaviours
The needle risk component of the Opiate Treatment Index (OTI) 17 was used in iours in the month preceding interview that placed assessing injecting behav respondents at risk of either contracting or transmitting blood borne viruses.
Heroin overdose
Those subjects who had ever used heroin were asked how many times they had overdosed, how long since they had last overdosed, whether they had ever been ow administered naloxone, whether they had witness another person overdose and h long since they had witnessed an overdose.
Transitions between the injection of heroin and amphetamines
Subjects were asked about their heroin and amphetamine use history, about ansitions between primary injection of the two dugs, circumstances and 
Health
The Health Scale of the OTI was used to gain some indication of the respondent's current state of health. This scale is divided into items addressing signs and ymptoms in each of the major organ systems, with one section specifically d health problems. Scores range from 0-52. The s focusing on injection-relate higher the score obtained, the poorer the overall health of the subject.
Social functioning
The Social Functioning scale of the OTI was administered. The scale measures ocial adjustment, social support and drug culture involvement over the es from 0-48. Higher scores indicate poorer s preceding six months. The scale rang social functioning.
Psychological functioning
Psychological adjustment was assessed using the 28 item version of the GHQ 18 .
This scale gives a global measure of non-psychotic psychopathology and is made up 
Criminal behaviours
The Criminality Scale of the OTI was used to measure property crimes, drug dealing, aud and violent crimes committed during the month preceding interview. The scale 6. Higher scores denote greater criminal involvement.
fr has a range of 0-1
Analyses
For continuous variables t-tests were employed. Categorical variables were analysed using chi 2 . Corresponding odds ratios (O.R.) and 95% confidence intervals (95% C.I.) were calculated. Where distributions were highly skewed, medians were reported. Relationships between age and major transition paths were examined by 6 NOVA and subsequent planned comparisons. In order to determine which factors associated with transitions between drug classes, multiple
. Backwards elimination of variables was used to priate models. All analyses were conducted using SYSTAT 19 .
A were independently logistic regressions were conducted select the most appro
RESULTS
Sample Characteristics
All subjects
The sample consisted of 296 regular injecting heroin and amphetamine users, recruited from all areas of Sydney. These comprised 151 current primary heroin users and 145 current primary amphetamine users. The mean age of subjects was 
Primary heroin and amphetamine injectors
The demographic characteristics of the groups of primary heroin and mphetamine injectors are presented in Table 1 . Primary heroin injectors were, on average, older than primary amphetamine injectors (29.0 v 26.6, t 294 =2.9, p<.01) and had fewer years of education (9.9 v =5.0, p<.001) . They were also more likely to be unemployed (82% v 52%, 10.8, t OR 4.2, 95% CI 2.5-7.1), to be enrolled 294 in drug treatment (52% v 12%, OR 6.4, record (44% v 12%, OR 5.5, 95% CI 95% CI 3.6-11.6), and to have a prison 3.0-9.9). There was no difference between the proportions of males in each group.
3.2
Drug use history
Primary heroin injectors
The mean age at the time of first injection was 18. In terms of the current study, it should be noted that 87% of the primary heroin users had used amphetamines, and 49% had done so in the preceding six months.
(SD 3.7, range 0-15). Fifty six percent of primary heroin users had experienced an overdose, 28% in the preceding 12 months.
Drug classes ever used and used in the preceding six months are presented in Table 2 . Polydrug use was extensive among primary heroin injectors. This group had used a lifetime mean of 8.5 (SD 2.7, range 2-10) drug classes, and 5.9 (SD 1.7, range 2-10) in the preceding six months. The most common drugs used in the preceding six months apart from heroin were tobacco (92%), cannabis (88%) and benzodiazepines (76%). Primary heroin users had injected a m 1 9 
Primary amphetamine injectors
The mean age of first injection was 18.8 yrs (SD 3.5, range 13-32). The mean age of first amphetamine use was 17.2 yrs (SD 2.8, range 10-28). The routes of initial amphetamine use were: nasal (60%), injection (21%) and oral (19%).
Amphetamines had been used for a median of 53 days (range 2-180) in the six months preceding interview. The mean SDS score for amphetamine dependence as 5.6 (SD 3.4, range 0-14). w cent of primary mphetamine injectors had used heroin, and 68% had done so in the preceding he age of first injection, the umber of drug classes ever used, number of drug classes ever injected, or jected amphetamines prior to heroin, or had ever injected heroin (N=121); iv) current primary amphetamine users who phetamines (N=24).
Polydrug use was extensive among the primary amphetamine injectors (Table 2 ).
Primary amphetamine users had used a mean of 8. Compared to primary heroin users, primary amphetamine users had used significantly more drug classes in the preceding six months (6.5 v 5.9, t 294 =3.2, p<.01). There were no differences between groups in t n number of drug classes injected in the preceding six months.
Transitions between heroin and amphetamine injecting
For the purposes of analysis, subjects were divided into four groups: i) current primary heroin users who injected heroin prior to amphetamines, or had never injected amphetamines (N=91); ii) current primary heroin users who had injected amphetamines prior to injecting heroin (n=60); iii) current primary amphetamine users who had in n injected heroin prior to injecting am
Primary heroin injectors i) Heroin first
Ninety one of the 151 primary heroin users (60%) had injected heroin prior to injecting amphetamines (N=67), or had never injected amphetamines (N=24) ( Table 3 ). The mean age of this group was 28.8 yrs (SD 8.9, range 16-57 yrs) and 11 5% were male. Only 6% of these 91 subjects thought it likely that amphetamines would become their main drug in the future.
ii) Amphetamines first
Sixty (40%) of the primary heroin users had injected amphetamine prior to injecting heroin. The mean age of this group was 29.4 yrs (SD 5.9, range 19-47 yrs) and 60% were male. Amphetamines were the main drug used prior to the injection of heroin in two thirds of these subjects (45 cases).
mths (range 1-48).
The median time between commencing to inject heroin and it becoming their main drug was 1.5 mths (range 1-120 mths). After heroin become their main drug, only 10% (6/60) of this group reported a period in which amphetamines became their main drug. The median length of time for which amphetamines was the main drug for these six subjects was 7.5
When asked the reasons why heroin became the main drug of these initial amphetamine injectors, the three most common responses were that they liked the effects of heroin (35/60), that heroin reduced their psychological distress (11/60), and that they did not like the negative psychological effects of 13 er and 7% had no partner. e, after heroin became eir main drug. Only 2% reported they committed less crime. s thought it likely that they would ever witch to amphetamines as their main drug. tamine injectors amphetamines (7/60). At the time of their transition to primary heroin use, 45% had a heroin using regular sexual partner, 28% a non-heroin using partn 2 After heroin became the main drug of this group, the majority reported that they spent more money on drugs than previously (82%) and they injected drugs more frequently (88%). Over half (59%) reported that they either increased the amount of crime that they committed, or started to commit crim th Only 7% of these primary heroin user s
Primary amphe iii) Amphetamines first
One hundred and twenty one (83%) of the 145 primary amphetamine users had injected amphetamines prior to ever injecting heroin (N=85), or had never injected heroin (N=36). The mean age of this group was 26.2 yrs (SD 5.9, range 6-43 yrs) and 60% were male. or which heroin was the ain drug of these subjects was 24 mths (range 1-252 mths). rolled in methadone maintenance (7/41). The emaining reasons were extremely varied.
1
After the commencement of regular amphetamine use, 34% (41/121) reported that there had been a period when they had made a transition in which heroin had become their main drug. The median length of time f m Those subjects who had made a transition from amphetamine use to heroin use were asked why they had made a further transition back to amphetamines as their main drug. The three main reasons were a dislike of the physical effects of heroin (9/41), being sick of the heroin lifestyle (7/41), and using amphetamines as an intoxicant while being en r 14 n percent thought it likely that they would use heroin again as their main rug.
Thirtee d iv) Heroin first
Twenty four (17%) of the primary amphetamine users had injected heroin prior to injecting amphetamines. The mean age of this group was 28.7 yrs (SD 8.6, ange 17-44 yrs) and 71% were male.
hich heroin was the main drug for these six subjects was 12 mths (range 1-48).
re able to work (3/24) and that they did not like the psychological effects f heroin (3/24). e use, 46% had an amphetamine using regular sexual artner, 17% a non-amphetamine using partner and 38% no partner. r In 63% (15/24) of these subjects heroin was the main drug they used prior to the injection of amphetamines. The median time between commencing to inject amphetamines and it becoming their main drug was 6 mths (range 1-336 mths).
After amphetamines became their main drug, 29% (7/24) of this group reported a period in which heroin became their main drug. The median length of time for w When asked the reasons why amphetamines became the main drug of these initial heroin injectors, the most common responses were that it increased their energy levels (9/24), a liking of the euphoric effects of amphetamines (4/24), that they we o After amphetamines became the main drug of group iv subjects, 42% stated that they spent more money on drugs, and 46% that they spent less money. Three quarters believed that they injected more frequently after amphetamines became their main drug. Only 21% reported that they either increased the amount of crime that they committed or started to commit crime after amphetamines became their main drug. ently used heroin as their primary drug (route AHA).
ome time (routes AH and AHA).
haracteristics of subjects analysed by transition route are presented in Table 4 .
Among current primary heroin injectors, 40% had injected amphetamines prior to heroin (route AH). Conversely, among current primary amphetamine injectors, only 16% had injected heroin prior to the injection of amphetamines (route HA). Although the majority of subjects (61%, N=181) had injected amphetamines prior to heroin (or had never injected heroin), 51% of subjects were now primary heroin users. While the transition from amphetamines to heroin predominated among these subjects, there had been considerable crossover between drug classes in both directions. 
Predictors of transitions between heroin and amphetamine injecting
In order to determine the independent factors associated with a transition between amphetamine and heroin injecting, logistic regressions were conducted.
Variables entered into the model predicting a transition between drug classes were: age, sex (males=1, females=0), drug first injected (heroin=0, 
injectors
Comparisons were made between current primary heroin and amphetamine injectors ( Table 5 ). Comparisons of drug use histories were presented in section 3.2.2 (above).
Needle r
(14% v 10%) or lent (24% v 21%) used jecting equipment during the month preceding interview (Table 5 ).
There were no significant differences in the proportions of primary heroin and amphetamine injectors who had borrowed in
Health
There was no significant difference between the OTI health scores of primary heroin and amphetamine injectors (18.8 v 18.0).
Social functioning
Primary heroin injectors had significantly higher OTI social functioning scores than primary amphetamine injectors (21.6 v 17.1), indicating poorer current social functioning (Table 5 ).
Psychological functioning
There were no significant differences between the GHQ scores of primary heroin and amphetamine injectors (9.9 v 9.3), or in the proportions of each group who exceeded the 4/5 cut-off for "caseness" (71% v 70%).
22
Criminal behaviours
While there was no significant difference in the proportions of primary heroin and amphetamine injectors who had committed crime in the preceding month (57% v 54%), primary heroin injectors had significantly higher OTI crime total scores (1.9 v 1.3, t 294 =2.6, p<.01), indicating higher degrees of criminal involvement (Table 5) .
Thus, while no more likely to have committed crime, heroin injectors committed crimes more frequently than amphetamine injectors. 
jectors
DISCUSSION
Major findings of the study
The major finding of this study was the complexity of transition patterns between primary injection of the two drug classes. While the transition from amphetamines to heroin injecting was more common than the reverse case, there Subjects who progressed via route HA first injected heroin, and then became primary amphetamine injectors. These represented a fifth of those subjects who initially injected heroin. Similarly, route AHA subjects initially injected amphetamines, and then made the expected transition to heroin. However these subjects, a quarter of all subjects who first injected amphetamines, subsequently made an unexpected transition back to primary amphetamine use. Similarly unexpected were the route HAH subjects, who first injected heroin, but became primary amphetamine injectors prior to a transition back to primary heroin injecting. As noted, the actual transitions back and forth were more complex still, with small proportions of subjects having made several transitions between the drug classes. The regression analyses indicated that the odds of a transition from amphetamine to heroin injecting were twice those of the reverse case, and that any transition was related to the length of time since initial injection.
However, while ov m
Age and transitions
In interpreting the results, particular attention must be paid to the age of subjects in the various groups. As a group, current primary amphetamine injectors were significantly younger than primary heroin users. At first glance this may be taken to indicate that this group will move on to primary heroin injecting. However, these broad figures do not capture the differences between groups of users who have progressed by different transition routes. Among primary amphetamine users, the youngest group (24.4 yrs) were those who had first injected amphetamines (or had never injected heroin). It is possible that this young group may well progress on to primarily injecting heroin. However, the current data do not indicate that this would necessarily be the end point of 
Reasons for transitions
The reasons given by subjects for making transitions are of interest. The main reasons given by subjects who had moved from injecting amphetamines to heroin related to a dislike of the negative physical and psychological effects of regular amphetamine use. Reasons for moving from heroin to amphetamines were more diverse. Negative aspects of heroin use, in particular its physical effects and the associated lifestyle were mentioned. So were perceived positive effects of amphetamines such as energy and euphoria, and the injection of amphetamines for intoxicating effects whilst maintained on methadone. It is worthy of note that groups ii (amphetamines-heroin) and iv (heroin-amphetamines) reported that they had tr change.
Effects of transitions on lifestyle
ng heroin to amphetamines, again most believed they injected ore frequently, but less than half spent more money on drugs and only a fifth to be nemployed, more likely to have been imprisoned, had poorer social functioning -related risk and both general nd psychological health. There are clear harms associated with injecting drug pe less of the primary drug of choice. A transition from heroin to There appeared to be quite disparate effects on lifestyle of making a transition.
Those subjects who made a transition from primarily injecting amphetamine to heroin reported that they injected more frequently, spent more money on drugs and committed more crime than previously. For subjects who moved from primarily injecti m engaged in more crime.
Comparisons of current primary heroin and amphetamine injectors
Current primary heroin uses were older, less educated, more likely u and greater criminal involvement. The overall picture is of a higher level of social dysfunction in comparison to the younger primary amphetamine injectors.
Primary amphetamine injectors, however, had higher levels of current polydrug use, and were no less likely to have borrowed or lent used injecting equipment.
There were also no differences in the general and psychiatric health of the two groups. In fact, nearly three quarters of each group exceeded the GHQ cut-off for psychiatric morbidity sufficiently severe to warrant clinical attention. Thus, while primary heroin injectors appear more socially dysfunctional, there is little to distinguish the two groups in terms of injection a use r se, regard amphetamines should not be viewed as a movement towards safer drug use.
Summary
In summary, transitions between the primary injection of heroin and amphetamines are common, and occur in both directions. Not only do the current data confirm the view that polydrug use is the norm among IDU, but that the general drug orientation of these groups may change in both the direction of
